# 1. Financial Performance ## A. Key Figures * **Revenue Growth:** **24%** YoY (Q1 FY25) · **~25%** YoY (Q1 vs Q1) * **EBITDA Growth:** **~40%** YoY (Q1 FY25) * **EBITDA Margin:** **37%** (Q1 FY25) (+700 bps YoY) · **34%** (FY25) * Power Cost (% of Revenue): 26% (FY22) → 36% (FY23) → 28% (FY23-24) * **Debt Repayment:** **₹210 Cr** from IPO proceeds used to retire long-term borrowings ## B. Revenue Growth * **Sustained Momentum:** Robust top-line expansion driven by capacity ramp-ups and a strong project pipeline, with confidence in maintaining **at least double-digit growth** over the next 2–3 years. * **Growth Visibility:** Revenue model for the 2,500 TPD plant based on fixed monthly fees, not proportional to capacity—highlighting that **3,800 TPD does not equate to linear revenue scaling**. * **Growth Rationale:** YoY metrics prioritized over QoQ due to lumpiness from timing of new plant commissioning, reinforcing need for trend-based analysis. ## C. EBITDA Margin * **Margin Expansion Achieved:** Significant improvement driven by **in-house argon production**, which carries highest value addition and now contributes **9% of total revenue** (up from 7%). * **Structural Support:** Onsite business wins (e.g., Tata Steel Metaliks) and higher utilization underpin margin resilience, with **no expectation of decline** from current 37% level. * **Forward Outlook:** Strategic push into argon marketing and value-added services seen as key lever for **further margin upside** over time. ## D. Power Cost Impact * **Cost Normalization:** Power cost as % of revenue declined to 28% in FY23-24 after spike in FY23, with prior-year distortion due to **abnormally high revenue during COVID-affected FY21-22**. ## E. Balance Sheet Strength * **Deleveraging Executed:** IPO proceeds deployment initiated with **₹210 Cr used to fully eliminate long-term debt**, establishing a strong, unlevered capital structure. * **Strategic Enabler:** Pan-India expansion supported by **post-IPO brand visibility**, **critical mass in core markets**, and robust balance sheet. --- # 2. Capacity & Utilization ## A. Key Figures * **Total Capacity:** **1,370 TPD** owned & operated · **3,800 TPD** total operational (incl. 2,500 TPD third-party plant) * **Planned Capacity:** **1,910 TPD** by end-FY26 · **2,130 TPD** in FY27 * **Capex Outlook:** **₹52 Cr** current CWIP · **₹250 Cr** committed over next 5 years * **New Plant Capex:** **₹160 Cr** for 220 TPD merchant plant ## B. Current Capacity * **Operational Scale:** Company operates across 3,800 TPD of total capacity, with 1,370 TPD from owned plants and significant off-balance-sheet contribution from a 2,500 TPD managed facility. * **Kurnool Ramp-Up:** Kurnool facility is operational with **60–65% utilization in Q1**, trending toward **85–90%** in second half, constrained initially by contract finalizations. * **High Utilization Elsewhere:** All non-Kurnool facilities are running at **full capacity**, reflecting strong underlying demand and efficient operations. ## C. New Projects * **Expansion Pipeline:** Three new facilities underway—two merchant plants in East and North India, and one onsite plant in North India (320 TPD)—with commissioning between Oct 2025 and Mar 2026. * **Revenue Certainty:** Upcoming onsite plant benefits from **take-or-pay agreement**, ensuring full revenue capture from day one regardless of physical utilization. * **Efficiency Gains:** Newly commissioned and under-construction plants are **significantly more power-efficient**, mitigating future exposure to energy cost volatility. * **Scalable Impact:** Raman KV estimates **~₹500 Cr annual revenue uplift** from ~600 TPD merchant capacity additions between FY25–FY26. --- # 3. Product & Segment Mix ## A. Key Figures * **Core Product Revenue:** **~90%** from oxygen, nitrogen, and argon * **EBITDA Margin:** **37%** blended · argon margins **1.5x–2x** higher * **Market Share:** **~4%** in core products * **TAM:** **₹14,000–15,000 Cr** (Frost & Sullivan) ## B. Argon Contribution * **Strategic Margin Driver:** Argon’s significantly higher margins—**1.5x to 2x** the blended EBITDA rate—are key to structural margin expansion as its revenue mix scales. * **Growth Trajectory:** Revenue contribution accelerating toward **>15% target** by FY26–FY27, supported by capacity ramp-up and favorable pricing dynamics. * **Market Opportunity:** Despite holding only **4% share** in core gases, the large **₹15,000 Cr TAM** provides a multi-year runway for volume and mix-led growth. ## C. Oxygen & Nitrogen * **Volume Backbone, Margin Drag:** Oxygen (~40% of market) and nitrogen form the revenue base but carry lower margins due to competitive pricing despite similar production costs. * **Core Revenue Pillar:** Together with argon, these air gases constitute nearly **90% of total revenue**, anchoring operational scale. ## D. Other Gases * **Hydrogen Pilot Underway:** Existing small-scale plant serves as a testbed for market demand, with **major investments** contingent on pilot outcomes. --- # 4. Expansion & Footprint ## A. Key Figures * **Acquisition Value:** **₹5.5 Cr** (Bangalore cylinder filling assets) ## B. Pan-India Strategy * **National Ambition:** Firm advancing **pan-India expansion** via organic and inorganic routes, targeting **North and West regions** to capture emerging industrial demand. * **Cluster Optimization:** Maintaining **cluster-based focus** in established East and South markets while scaling nationally, enhancing operational efficiency. ## C. Regional Presence * **Strategic South India Hub:** **Karnataka’s location** between Hyderabad and Bangalore strengthens market access and supports high-value segments like **medical oxygen supply**. * **Local Infrastructure Advantage:** Presence of a **cylinder filling station in Bangalore** enables full gas portfolio delivery, improving customer reach and service reliability. ## D. M&A Activity * **Inorganic Growth Execution:** **Bangalore acquisition** marks strategic entry into a key market, enhancing distribution reach and creating synergies with the **Kurnool production facility**. --- # 5. Customer & Contract Mix ## A. Key Figures * **Revenue Mix:** **~20%** from government/PSU clients * **Market Share:** **~25%** held by each of the two largest competitors (Linde India, Inox Air Products) * **Customer Reach:** **300–400 customers** served within 500 km by bulk facilities * **Onsite Revenue:** **~₹25 Cr** annual revenue from a 300-ton onsite plant ## B. Government Clients * **Contract Structure:** Government/PSU contracts are shorter (1–2 years) due to retendering norms, though long-term relationships persist despite **similar payment terms** to private clients. ## C. Key Customer Segments * **Facility Models:** Onsite plants enable direct pipeline supply with **lower revenue potential** due to customer cost absorption, while bulk distribution facilities serve a wide regional customer base from centralized locations. * **Competitive Positioning:** Company is the **fourth or fifth largest player** in a market dominated by Linde and Inox, with several other MNCs present. * **Hydrogen Market Focus:** Current hydrogen demand driven by **non-traditional segments**—power plants and Vanaspati units—diverging from emerging green hydrogen applications. --- # 6. Risks & Input Costs ## A. Key Figures * **Power Expenses:** **36%** of revenue in FY23 (₹73 Cr) (+10 pp from FY22) ## B. Power Price Volatility * **Cost Surge Absorbed:** Sharp increase in power costs driven by tariff hikes in the South, with expenses rising to 36% of revenue in FY23. * **Near-Term Relief Expected:** Management does not foresee similar cost surges ahead, citing stabilization in tariffs and improved procurement strategy. * **Procurement Optimization:** Active use of power exchange purchases at **discounted rates** enhanced cost efficiency during volatile periods. ## C. Helium Supply Dependence * **Full Import Reliance:** Helium supply remains entirely dependent on imports due to absence of domestic production in India. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth (Q1 FY25):** **25%** YoY * **Market Share:** **~4%** (vs. global peers at ~25%) * **Long-Term EBITDA Margin Outlook:** Stabilize **around current levels or slightly higher** ## B. Revenue Projections * **H2 FY25 to Outperform H1:** Revenue and margin growth expected in Q2, driven by commissioning of **two new projects**. * **Lumpy Revenue Pattern:** No inherent seasonality; QoQ fluctuations likely due to ad-hoc orders in project engineering (equipment & medical gas systems). ## C. Growth Trajectory * **Sustained High Growth Ahead:** Company expects to grow **significantly above industry average** (citing strong Q1 momentum), supported by scalable project pipeline and **cash surplus enabling capex**. * **Long-Term Runway:** Small base vs. global peers provides **asymmetric growth potential**; hydrogen flagged as strategic opportunity pending pilot results.